AKT1 and neoplasm: Future research should include mechanistic studies—such as dual-luciferase assays and pathway analyses—to validate the proposed circ_0027478/miR-1236-3p/AFP axis and its regulatory impact on tumor progression via pathways like PI3K/Akt.